Clinical Trial

Clinical and Mechanistic Research on Autogenous Arteriovenous Fistula in Hemodialysis Patients

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 10, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to investigate the long-term clinical outcomes and molecular mechanisms of autogenous arteriovenous fistula (AVF) maturation failure in uremic patients. The primary goal is to develop a precision prediction model integrating clinical, imaging, and biomarker data, while secondary objectives focus on identifying key molecular targets regulating AVF maturation.
Trial Details
NCT Number NCT07058441
Lead Sponsor Ai Peng
Conditions Arteriovenous Fistula Maturation Failure in End-stage Renal Disease
Enrollment 100 participants
Start Date 2024-10-01
Primary Completion 2025-08-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-10